DX3-213B

Pricing Availability   Qty
说明: Potent NDUFS7 antagonist
化学名: (4,4-Difluoro-1-piperidinyl)[(3R)-1-[[4-[(1-methylethyl)sulfonyl]phenyl]sulfonyl]-3-piperidinyl]methanone
纯度: ≥97% (HPLC)
说明书
引用文献
评论
文献 (1)

生物活性 for DX3-213B

DX3-213B is a potent oxidative phosphorylation (OXPHOS) complex I (also known as NDUFS7) antagonist (IC50 = 3.6 nM). DX3-213B impairs ATP generation (IC50 = 11 nM) and inhibits the proliferation of MIA PaCa-2 cells (IC50 = 9 nM) in galactose-containing media. In vivo, DX3-213B significantly delays tumor growth in a syngeneic mouse model of pancreatic cancer. DX3-213B is orally bioavailable.

许可信息

Sold under license from the University of Michigan

技术数据 for DX3-213B

分子量 478.57
公式 C20H28F2N2O5S2
储存 Store at -20°C
纯度 ≥97% (HPLC)
CAS Number 2749555-66-4
PubChem ID 162365370
InChI Key HLSJMSNPBRGRGL-MRXNPFEDSA-N
Smiles O=S(N1C[C@H](C(N2CCC(CC2)(F)F)=O)CCC1)(C3=CC=C(S(C(C)C)(=O)=O)C=C3)=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for DX3-213B

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
DMSO 23.93 50

制备储备液 for DX3-213B

以下数据基于产品分子量 478.57。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
0.5 mM 4.18 mL 20.9 mL 41.79 mL
2.5 mM 0.84 mL 4.18 mL 8.36 mL
5 mM 0.42 mL 2.09 mL 4.18 mL
25 mM 0.08 mL 0.42 mL 0.84 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

参考文献 for DX3-213B

参考文献是支持产品生物活性的出版物。

Xu et al (2023) First-in-class NADH/Ubiquinone oxidoreductase core subunit S7 (NDUFS7) antagonist for the treatment of pancreatic cancer. ACS Pharmacol.Transl.Sci. 6 1164 PMID: 37588763

Xue et al (2022) Multiparameter optimization of oxidative phosphorylation inhibitors for the treatment of pancreatic cancer. J.Med.Chem. 65 3404 PMID: 35167303


If you know of a relevant reference for DX3-213B, please let us know.

按标靶查看相关产品

按产品操作查看相关产品

查看全部 Oxidative Phosphorylation Antagonists

关键词: DX3-213B, DX3-213B supplier, OXPHOS, potent, orally, bioavailable, complex, 1, antogonist, oxidative, phosphorylation, pancreatic, cancer, in, vivo, NDUFS7, Oxidative, Phosphorylation, 8070, Tocris Bioscience

篇 DX3-213B 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 DX3-213B 的引用文献。 您是否知道使用了 Tocris DX3-213B 的优秀论文? 请告知我们.

DX3-213B 的评论

目前没有该产品的评论。 Be the first to review DX3-213B and earn rewards!

Have you used DX3-213B?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Cancer Metabolism Research Product Guide

Cancer Metabolism Research Product Guide

This product guide reviews some of the main areas in cancer metabolism research and lists around 150 products that can be used to investigate metabolic pathways in cancer including: